Document Detail


CDKs and CKIs: molecular targets for tissue remodelling.
MedLine Citation:
PMID:  12402499     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Effective tissue remodelling is essential to the survival of adult organs. Many of the signalling pathways that control these cellular decisions are regulated by nuclear interactions of cell-cycle proteins. Molecules that target cyclin-dependent kinases (CDKs) or CDK inhibitors (CKIs) represent a new class of therapeutic agents that influence tissue remodelling in several organ systems. An understanding of their cell-specific functions is leading to the development of exciting and bold approaches to the treatment cancer, cardiovascular disease and other diseases.
Authors:
Elizabeth G Nabel
Related Documents :
17662109 - A transcription factor of lipid synthesis, sterol regulatory element-binding protein (s...
10620399 - Changes in cyclin dependent kinase expression and activity accompanying lens fiber cell...
10893799 - Effects of alpha-difluoromethylornithine on the cyclin a expression in hep-2 cells.
20113529 - Differential roles of cyclin d1 and d3 in pancreatic ductal adenocarcinoma.
16140969 - Activin a mediates growth inhibition and cell cycle arrest through smads in human breas...
15126379 - Caffeine inhibits cell proliferation by g0/g1 phase arrest in jb6 cells.
7459259 - Morphological analysis of malignancy: a comparative study of transplanted brain tumours.
159319 - Cell-mediated lympholysis by human maternal and neonatal lymphocytes: mother's reactivi...
19709599 - Direct toxicity of rose bengal in mcf-7 cell line: role of apoptosis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  1     ISSN:  1474-1776     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2002 Aug 
Date Detail:
Created Date:  2002-10-29     Completed Date:  2002-12-03     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  587-98     Citation Subset:  IM    
Affiliation:
Cardiovascular Branch, National Heart, Lung and Blood Institute/National Institutes of Health, Building 10/8C103, 10 Center Drive, Bethesda, Maryland 20892, USA. enabel@nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cyclin-Dependent Kinases / antagonists & inhibitors*,  metabolism
Cyclins / antagonists & inhibitors,  metabolism
Drug Delivery Systems / methods*
Enzyme Inhibitors / pharmacology*,  therapeutic use
Humans
Signal Transduction / drug effects,  physiology
Tissue Survival / drug effects*,  physiology
Chemical
Reg. No./Substance:
0/Cyclins; 0/Enzyme Inhibitors; EC 2.7.11.22/Cyclin-Dependent Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New tools and concepts for modern organic synthesis.
Next Document:  The use of constitutively active GPCRs in drug discovery and functional genomics.